Sexual characteristics of patients with prostate cancer seen for radiation treatment

Background Prostate cancer was estimated to be the second most diagnosed cancer and the fifth leading cause of cancer mortality among men, with an estimated 1.4 million new cases and 375,000 deaths globally in 2020. There are significant changes in sexual activities and subsequent changes in quality of life associated with the diagnosis and treatment of prostate cancer. Sexual problems experienced by prostate cancer patients include erectile dysfunction, reduced sexual desire, reduced sexual function, problems with ejaculation, as well as problems with orgasm, and these could occur before and/or after treatment. This study aims to highlight the sexual characteristics of prostate cancer patients, which would help identify altered sexuality that might require intervention by healthcare providers. Method All patients who presented with pathologically diagnosed, organ-confined prostate cancer referred for high-dose-rate brachytherapy were approached for participation in the study. An interviewer-administered questionnaire was administered to the consenting patients. Results A total of 56 patients gave consent for the study out of 60. All the patients were married, with 5 (8.9%) having multiple wives. Only ten respondents (17.9%) reported having other sexual partners besides their wives. More than half of the patients (34) (60.7%) started having sexual intercourse between the ages of 18 and 20. Many patients claimed that the diagnosis of prostate cancer had affected their sexual lives. About half of the respondents (44.6%) believed that their partners were less satisfied with their sexual performance, as evidenced by the loss of partners (5.4%), partners refusing sexual advances (14.3%), partners complaints (10.7%), and partners' reduced inclination to ask for sex (33.9%). One patient expressed fears of passing the disease to their partners. Conclusion The management of prostate cancer should include sex therapy and rehabilitation in couples from the point of diagnosis to maintain sexual function as close as possible to that in the general population in order to maintain an improved quality of life.

[1]  V. Sewram,et al.  A comparison of clinicopathologic features of prostate cancer between Nigerian and South African black men , 2022, African Journal of Urology.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  J. Obafunwa,et al.  Epidemiology of Prostate Cancer in NIGERIA: Observations at Lagos State University Teaching Hospital , 2019 .

[4]  Yaqun Wang,et al.  A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer , 2019, Advances in radiation oncology.

[5]  M. Borre,et al.  Scandinavian Prostate Cancer Patients’ Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment , 2018, Sexual medicine.

[6]  H. Putter,et al.  Suitable sexual health care according to men with prostate cancer and their partners , 2018, Supportive Care in Cancer.

[7]  S. Elliott,et al.  Sexual Recovery Following Prostate Cancer: Recommendations From 2 Established Canadian Sexual Rehabilitation Clinics. , 2017, Sexual medicine reviews.

[8]  J. Albaugh,et al.  Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners , 2017, BMC Urology.

[9]  R. Wassersug,et al.  The perspective of prostate cancer patients and patients' partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples , 2016, Psycho-oncology.

[10]  Sowunmi Anthonia,et al.  Pattern of prostate cancer among a Nigerian population: A study in a single tertiary care centre. , 2016, Nigerian Journal of Medicine.

[11]  L. López-Carrillo,et al.  History of gonorrhea and prostate cancer in a population-based case-control study in Mexico. , 2016, Cancer epidemiology.

[12]  W. Kwan,et al.  Impact of Prostate Cancer Treatment on the Sexual Quality of Life for Men-Who-Have-Sex-with-Men. , 2015, The journal of sexual medicine.

[13]  A. Rafindadi,et al.  A ten-year study of prostate cancer specimens at Ahmadu Bello University Teaching Hospital (A.B.U.T.H), Zaria, Nigeria , 2015 .

[14]  N. Van As,et al.  Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer , 2014, International journal of clinical practice.

[15]  F. Penedo,et al.  Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy. , 2014, The journal of sexual medicine.

[16]  C. Stief,et al.  [Low-risk prostate cancer]. , 2014, Der Urologe. Ausg. A.

[17]  I. Thompson,et al.  Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences. , 2013, The journal of sexual medicine.

[18]  W. Hellstrom,et al.  The pre‐treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer , 2013, Andrology.

[19]  J. Witte,et al.  Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent , 2013, Prostate cancer.

[20]  W. Hellstrom,et al.  Sexual dysfunction following radical prostatectomy. , 2012, Journal of andrology.

[21]  G. Hellawell,et al.  High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer. , 2012, The British journal of radiology.

[22]  J. S. Hyun.  Prostate Cancer and Sexual Function , 2012, The world journal of men's health.

[23]  K. Matsushita,et al.  The evolution of orgasmic pain (dysorgasmia) following radical prostatectomy. , 2012, The journal of sexual medicine.

[24]  C. Nelson,et al.  The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer. , 2011, The journal of sexual medicine.

[25]  B. Jiann.  Effect of Alcohol Consumption on the Risk of Erectile Dysfunction , 2010 .

[26]  A. Nehra,et al.  Defining sexual function after radical retropubic prostatectomy. , 2010, Urologic oncology.

[27]  David S. Shimm,et al.  Perez and Brady's Principles and Practice of Radiation Oncology , 2008 .

[28]  J. de Pina-Cabral.  World , 2004, Science.

[29]  Todd M. Moore,et al.  Erectile Dysfunction in Early, Middle, and Late Adulthood: Symptom Patterns and Psychosocial Correlates , 2003, Journal of sex & marital therapy.

[30]  J. Robinson,et al.  Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[31]  Y. Kawanishi,et al.  Effect of radical retropubic prostatectomy on erectile function, evaluated before and after surgery using colour Doppler ultrasonography and nocturnal penile tumescence monitoring , 2001, BJU international.

[32]  J. Moul,et al.  The development of erectile dysfunction in men treated for prostate cancer. , 2001, The Journal of urology.

[33]  A. Montejo,et al.  Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. , 2001, The Journal of clinical psychiatry.

[34]  R A Stephenson,et al.  Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.

[35]  R. Hayes,et al.  Sexual behaviour, STDs and risks for prostate cancer , 2000, British Journal of Cancer.

[36]  E. Cerrada,et al.  [Antidepressants and sexual dysfunction]. , 1999, Atencion primaria.

[37]  D. Lubeck,et al.  Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. , 1998, The Journal of urology.

[38]  F. Labrie,et al.  Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration , 1988, Archives of sexual behavior.

[39]  K. A. Harrison,et al.  Trade Flows and Employment Outcomes in Nigeria , 2010 .

[40]  M. Retsky,et al.  Some Oxidative Stress Biomarkers among Patients with Prostate Cancer in Sokoto, North Western Nigeria , 2022, Open Journal of Blood Diseases.

[41]  J. Sønksen,et al.  Sexual Function in Elderly Men Receiving Androgen Deprivation Therapy (ADT). , 2014, Sexual medicine reviews.

[42]  Ming Zhou.  Tumors of the Prostate , 2013 .

[43]  M. Eble,et al.  Erectile dysfunction after external beam radiotherapy for prostate cancer. , 2009, European urology.

[44]  U. Isiugo-abanihe,et al.  Prevalence and factors associated with extramarital sex among Nigerian Men , 2007 .

[45]  J. Goedert,et al.  Sexual behavior and evidence for an infectious cause of prostate cancer. , 2001, Epidemiologic reviews.

[46]  S. Kaasa,et al.  Quality of life in prostate cancer , 1992, The Prostate. Supplement.